AI-generated summary
The authors systematically reviewed 27 controlled laboratory animal studies published from 2009 to June 2022 on photobiomodulation and neuroinflammation. They report that photobiomodulation showed anti-inflammatory properties across several conditions, including traumatic brain injury, ischemia, neurodegenerative conditions and spinal cord injury. The authors conclude that transcranial photobiomodulation is a promising strategy, although the evidence comes from animal studies.
- Studies included
- 27
- Who or what was studied
- Laboratory animal models of neuroinflammation and related brain and spinal cord conditions
- Limits stated in the abstract
- The evidence comes from laboratory animal studies, and the abstract does not report wavelengths, doses or the certainty of the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Neuroinflammation is a response that involves different cell lineages of the central nervous system, such as neurons and glial cells. Among the non-pharmacological interventions for neuroinflammation, photobiomodulation (PBM) is gaining prominence because of its beneficial effects found in experimental brain research. We systematically reviewed the effects of PBM on laboratory animal models, specially to investigate potential benefits of PBM as an efficient anti-inflammatory therapy.
Methods
We conducted a systematic search on the bibliographic databases (PubMed and ScienceDirect) with the keywords based on MeSH terms: photobiomodulation, low-level laser therapy, brain, neuroinflammation, inflammation, cytokine, and microglia. Data search was limited from 2009 to June 2022. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The initial systematic search identified 140 articles. Among them, 54 articles were removed for duplication and 59 articles by screening. Therefore, 27 studies met the inclusion criteria.
Results
The studies showed that PBM has anti-inflammatory properties in several conditions, such as traumatic brain injury, edema formation and hyperalgesia, ischemia, neurodegenerative conditions, aging, epilepsy, depression, and spinal cord injury.
Conclusion
Taken together, these results indicate that transcranial PBM therapy is a promising strategy to treat brain pathological conditions induced by neuroinflammation.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuroinflammation, Systematic review, Low-level laser therapy, Traumatic brain injury, Brain injury, Inflammation, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.